Literature DB >> 2033092

Presence of oestrogen receptors on target cells and antiproliferative activity of estramustine phosphate: positive correlation for human tumours in vitro.

J Pavelić1, I Zgradić, K Pavelić.   

Abstract

Incubation with estramustine phosphate for 24 h inhibited DNA, RNA and protein synthesis in primary cultures of human kidney, mammary, prostatic, cervical and endometrial carcinoma. Not only the presence, but also the concentration of oestrogen receptors correlated with estramustine phosphate effects on tumour cell proliferation.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2033092     DOI： 10.1007/bf01625432

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN： 0171-5216            Impact factor:   4.553


  26 in total

1.  Protein factor that inhibits binding and promotes release of androgen-receptor complex from nuclear chromatin.

Authors:  C I Shyr; S Liao
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

2.  Nuclear protein matrix as a target for estramustine-induced cell death.

Authors:  B Hartley-Asp; E Kruse
Journal:  Prostate       Date:  1986       Impact factor: 4.104

3.  Purification and distribution of a major protein in rat prostate that binds estramustine, a nitrogen mustard derivative of estradiol-17 beta.

Authors:  B Forsgren; P Björk; K Carlström; J A Gustafsson; A Pousette; B Högberg
Journal:  Proc Natl Acad Sci U S A       Date:  1979-07       Impact factor: 11.205

4.  Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.

Authors:  P Björk; B Forsgren; J A Gustafsson; A Pousette; B Högberg
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

5.  Growth and cell survival following treatment with estramustine nor-nitrogen mustard, estradiol and testosterone of a human prostatic cancer cell line (DU 145).

Authors:  B Hartley-Asp; P O Gunnarsson
Journal:  J Urol       Date:  1982-04       Impact factor: 7.450

6.  Treatment of advanced carcinoma of the prostate with estramustine phosphate.

Authors:  R Nagel; C P Köllin
Journal:  Br J Urol       Date:  1977-02

7.  Estramustine-induced mitotic arrest in two human prostatic carcinoma cell lines DU 145 and PC-3.

Authors:  B Hartley-Asp
Journal:  Prostate       Date:  1984       Impact factor: 4.104

8.  Estramustine phosphate-reduced proliferation of murine and human cell lines and murine transplantable tumors.

Authors:  K Pavelić; I Zgradić; M Osmak; M Popović
Journal:  Res Exp Med (Berl)       Date:  1985

9.  Growth of human urological tumors on extracellular matrix as a model for the in vitro cultivation of primary human tumor explants.

Authors:  K Pavelic; M A Bulbul; H K Slocum; Z P Pavelic; Y M Rustum; M J Niedbala; R J Bernacki
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

10.  Distribution and metabolism of estramustine in HeLa cells and the human prostatic tumour cell line 1013L.

Authors:  E Kruse; S A Johansson; B Hartley-Asp; P O Gunnarsson
Journal:  Biochem Pharmacol       Date:  1988-08-15       Impact factor: 5.858
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.